The revenue stands at ₹4,197.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.07 per cent from ₹3,303.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.84 per cent.
Operating Profit stands at ₹1,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.67 per cent from ₹1,078.00 crore. This corresponds to a year-on-year *(YoY) growth of 37.23 per cent.
PBDT stands at ₹1,037.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.67 per cent from ₹1,020.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.75 per cent.
Profit Before Tax stands at ₹529.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 35.01 per cent from ₹814.00 crore. This corresponds to a year-on-year *(YoY) decline of 20.45 per cent.
Net Profit stands at ₹364.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 42.68 per cent from ₹635.00 crore. This represents a 26.91 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 1.27% | 4.40% | 9.38% | 19.18% | 17.96% | 44.03% |
| Sun Pharma.Inds. | 0.57% | 2.84% | 7.10% | 11.47% | 7.46% | 14.03% |
| Divi's Lab. | 1.33% | 4.15% | 5.13% | 17.12% | 3.14% | -0.47% |
| Cipla | 0.88% | 0.42% | 5.98% | 22.37% | 0.27% | -2.62% |
| Zydus Lifesci. | 0.69% | 3.30% | 5.65% | 31.51% | 23.91% | 15.02% |
| Dr Reddy's Labs | -0.42% | 0.88% | 7.29% | 14.41% | 10.15% | 4.48% |
Chairman/ED & CEO : Samir Mehta
ED / MD / Promoter : Aman Mehta
Non-Exec & Non-Independent Dir : Jindal Mehta
Lead Independent Non Executive Director : Manish Choksi
Independent Non Exe. Director : Ameera Sushil Shah
Independent Non Exe. Director : Nayantara Bali
Independent Non Exe. Director : Nikhil Khattau
Company Sec. & Compli. Officer : Chintan M. Trivedi
Chairman Emeritus : Sudhir Mehta